Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
NHS England Appoints Leading Clinicians To Board
NHS England has added a wealth of clinical expertise and experience to its board with […]
ENHERTU® Type II Variation Application Validated by EMA for the Treatment of HER2 Mutant Metastatic Non-Small Cell Lung Cancer
Daiichi Sankyo has announced that the European Medicines Agency (EMA) has validated the Type II […]
BioSpace Names Most Promising New Biopharma Companies to Watch in 2023
BioSpace, the leading life sciences news and careers site, has announced its 2023 selections for […]
Actimed Therapeutics Closes Second Tranche of £10m Seed Financing
Actimed Therapeutics, a UK based clinical stage specialty pharmaceutical company focused on bringing innovation to […]
Orano Med Starts Phase I Trial With Alpha Radioligand Therapy 212Pb-GRPR in Patients With Solid Tumors
Orano Med, a clinical stage radiopharmaceutical company, has announced that the first patient has been […]
CNS Pharmaceuticals Appoints Faith L. Charles, JD as Chair of the Board of Directors
CNS Pharmaceuticals, a biopharmaceutical company specializing in the development of novel treatments for primary and […]
A Record Year For People Receiving NHS Cancer Treatment
Thousands more people started vital treatment for cancer over the last year compared to before […]
NMD Pharma Appoints Mike Heffernan as Chairman of Board of Directors
NMD Pharma A/S, a clinical-stage biotech company developing first-in-class, small molecule ClC-1 inhibitors for neuromuscular […]
Everest Medicines Announces New Strategic Plans, Reinforcing Transformation into a Fully Integrated Biopharmaceutical Company
Everest Medicines, a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative medicines […]
Legend Biotech Announces Acceptance of Its New Drug Application (NDA) for Ciltacabtagene Autoleucel (Cilta-Cel) in China
Legend Biotech Corporation, a global biotechnology company developing, manufacturing and commercializing novel therapies to treat […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more